News for Regeneron Pharmaceuticals Inc - Google Finance

REGENERON PHARMACEUTICALS INC : Sanofi and Regeneron Announce ...

Tue, 21 May 2013 13:07:22 GMT

REGENERON PHARMACEUTICALS INC : Sanofi and Regeneron Announce ...
4-traders (press release) - 4 hours ago

PARISand TARRYTOWN, N.Y., May 21, 2013/PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicinepublished online the positive ...

Regeneron-Sanofi Asthma Drug Shows Promising Early Results - Fox Business
Regeneron, Sanofi asthma drug seen as potential game changer - Reuters AlertNet

Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare ...

Mon, 20 May 2013 17:53:25 GMT

Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare ...
Seeking Alpha - May 20, 2013

But it's nice to be able to have the opportunity to update everybody on what's going on the Regeneron because the last year has really been a year of transformation for us in many ways.

Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...

Sun, 19 May 2013 16:39:16 GMT

Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...
Insider Monkey (blog) - May 19, 2013

What to watch at ASCO Regeneron Pharmaceuticals Inc (NASDAQ:REGN), perhaps best known for its highly successful wet age-related macular degeneration drug Eylea, released two promising abstracts for ASCO on monoclonal antibodies with potential ...

Regeneron Pharmaceuticals Inc. (REGN) Has Risen To A New High On Q1 ...

Fri, 03 May 2013 20:14:51 GMT

Regeneron Pharmaceuticals Inc. (REGN) Has Risen To A New High On Q1 ...
NASDAQ - May 3, 2013

(RTTNews.com) - Regeneron Pharmaceuticals Inc. ( REGN ) reported first quarter net income of $0.90 per share Friday morning, up from $0.11 per share in the prior year.

Regeneron Pharmaceuticals, Inc: Eylea Fundamentals Improving Amid Thinning ...

Thu, 09 May 2013 15:36:48 GMT

Regeneron Pharmaceuticals, Inc: Eylea Fundamentals Improving Amid Thinning ...
iStockAnalyst (press release) - May 9, 2013

(By Mani) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares are on the bullish territory on Eylea fundamentals, which continue to improve with long-term sustainability of ophthalmology related revenues.

Regeneron Pharms Rating Reiterated by TheStreet (REGN) - Mideast Time
Regeneron Pharms Receives Neutral Rating from Zacks (REGN) - Daily Political

NASDAQ Active Stock Watch List: Idenix Pharmaceuticals Inc. (NASDAQ:IDIX ...

Wed, 15 May 2013 12:27:10 GMT

NASDAQ Active Stock Watch List: Idenix Pharmaceuticals Inc. (NASDAQ:IDIX ...
SBWire (press release) - May 15, 2013

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally closed ...

Regeneron Pharmaceuticals Inc (REGN): Key Data To Keep An Eye On

Fri, 26 Apr 2013 15:54:36 GMT

Regeneron Pharmaceuticals Inc (REGN): Key Data To Keep An Eye On
Insider Monkey (blog) - Apr 26, 2013

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) investors should be aware of an increase in enthusiasm from smart money in recent months.

My top stock pick - MarketWatch

The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron ...

Thu, 16 May 2013 17:11:21 GMT

The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron ...
Sacramento Bee - May 16, 2013

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic Health Inc. (Nasdaq:GHDX), Sanofi (NYSE:SNY), Regeneron Pharmaceuticals, ...

REGENERON PHARMACEUTICALS INC : Regeneron Acquires Full Rights to ...

Fri, 03 May 2013 10:40:45 GMT

REGENERON PHARMACEUTICALS INC : Regeneron Acquires Full Rights to ...
4-traders (press release) - May 3, 2013

TARRYTOWN, N.Y., May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at ...

Spectra Energy Corp . ( NYSE : SE ) and Regeneron Pharmaceuticals Inc ... - Property Mentor
(REGN:NASDAQ GS) - Businessweek

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ ...

Tue, 07 May 2013 13:03:57 GMT

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ ...
SBWire (press release) - May 7, 2013

Regeneron Pharms Rating Increased to Buy at Brean Murray (REGN) - Daily Political
FEATURE-Fast climbing biotech Regeneron still has room to grow - Reuters